Bafna Pharmaceuticals
BAFNAPHNSE

Bafna Pharmaceuticals

₹301.755.90 (1.99%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
301.00
Today’s high
301.75
52 week low
94.77
52 week high
318.50
Open price
301.75
Previous close
295.85
Live volume
3,079
Lower circuit
289.95
Upper circuit
301.75

Fundamentals

Market Cap
₹702Cr
ROE
11.54%
P/E Ratio(TTM)
90.15
EPS(TTM)
3.29
P/B Ratio
7.30
Dividend Yield
0.00%
Industry P/E
50.83
Book Value
40.64
Debt to Equity
0.39
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
JUN '26
Revenue (Cr)
₹28.49
-35.25%
Profit (Cr)
₹0.08
-97.09%
015304560
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Revenue growthValue
1Y (TTM)-19%
3Y CAGR+9%
Profit growthValue
1Y (TTM)-98%
3Y CAGR-1%

About

Bafna Pharmaceuticals Limited manufactures pharmaceutical formulations, including betalactum and non-betalactum products, for domestic and export markets.;
CEO/MD
Bafna Mahaveer Chand
Founded in
1995
NSE symbol
BAFNAPH

Shareholding pattern

Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Shareholder details

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹2,814.00
+3.20 (0.11%)
L
    H
    21,361.1931.515.96
    PfizerPFIZER
    ₹4,596.50
    -13.20 (0.29%)
    L
      H
      21,107.3228.715.02
      ₹6,851.00
      -93.00 (1.34%)
      L
        H
        17,327.00102.1519.85
        Natco PharmaNATCOPHARM
        ₹838.30
        +9.65 (1.16%)
        L
          H
          14,848.2112.971.61
          2026
          11
          Aug
          Quarterly Result
          Release date
          29
          May
          Annual Result
          Release date
          11
          Feb
          Quarterly Result
          Release date
          2025
          11
          Nov
          Quarterly Result
          Release date
          12
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks